Canada markets close in 3 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.04-0.12 (-1.68%)
As of 3:57PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 51.43B
Enterprise Value 31.02B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)197.90
Price/Book (mrq)2.81
Enterprise Value/Revenue 3157.96
Enterprise Value/EBITDA 7-7.90

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-39.58%
S&P500 52-Week Change 327.40%
52 Week High 319.00
52 Week Low 35.81
50-Day Moving Average 37.68
200-Day Moving Average 38.10

Share Statistics

Avg Vol (3 month) 34.31M
Avg Vol (10 day) 32.4M
Shares Outstanding 5210.36M
Implied Shares Outstanding 6N/A
Float 8206.97M
% Held by Insiders 11.66%
% Held by Institutions 135.96%
Shares Short (Sep. 29, 2021) 445.21M
Short Ratio (Sep. 29, 2021) 412.06
Short % of Float (Sep. 29, 2021) 421.85%
Short % of Shares Outstanding (Sep. 29, 2021) 421.49%
Shares Short (prior month Aug. 30, 2021) 443.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun. 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-3,117.70%

Management Effectiveness

Return on Assets (ttm)-24.33%
Return on Equity (ttm)-40.78%

Income Statement

Revenue (ttm)6.46M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)2.10%
Gross Profit (ttm)-86.83M
EBITDA -198.09M
Net Income Avi to Common (ttm)-141.71M
Diluted EPS (ttm)-0.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)443.68M
Total Cash Per Share (mrq)2.11
Total Debt (mrq)33.8M
Total Debt/Equity (mrq)6.65
Current Ratio (mrq)10.48
Book Value Per Share (mrq)2.42

Cash Flow Statement

Operating Cash Flow (ttm)-256.7M
Levered Free Cash Flow (ttm)-177.41M